Global Information Lookup Global Information

Substrate reduction therapy information


Substrate reduction therapy offers an approach to treatment of certain metabolic disorders, especially glycogen storage diseases and lysosomal storage disorders. In a storage disorder, a critical failure in a metabolic pathway prevents cellular breakdown and disposal of some large molecule. If residual breakdown through other pathways is insufficient to prevent harmful accumulation, the molecule accumulates in the cell and eventually interferes with normal biological processes. Examples of lysosomal storage disorders include Gaucher's disease, Tay–Sachs disease, Sandhoff disease, and Sanfilippo syndrome.

In a metabolic or genetic pathway, enzymes catalyze a series of reactions. Each enzyme is regulated or mediated by one gene through its RNA and protein products. At each phase in the pathway, enzyme activity catalyzes a reaction in which a precursor molecule (the substrate) is transformed into its next intermediate state. Failure of the metabolic pathway leads to accumulation of the substrate, with possible harmful effects. Substrate reduction therapy addresses this failure by reducing the level of the substrate to a point where residual degradative activity is sufficient to prevent substrate accumulation.

and 21 Related for: Substrate reduction therapy information

Request time (Page generated in 0.8651 seconds.)

Substrate reduction therapy

Last Update:

Substrate reduction therapy offers an approach to treatment of certain metabolic disorders, especially glycogen storage diseases and lysosomal storage...

Word Count : 528

Enzyme replacement therapy

Last Update:

patients with enzyme or protein deficiencies include substrate reduction therapy, gene therapy, and bone-marrow derived stem cell transplantation.[1]...

Word Count : 1367

Metachromatic leukodystrophy

Last Update:

therapy, enzyme replacement therapy (ERT), substrate reduction therapy (SRT), and potentially enzyme enhancement therapy (EET). In addition to the clinical...

Word Count : 3183

Fabry disease

Last Update:

therapy: Replacement of the missing enzyme to clear the lipids (GL-3) from the cells Substrate synthesis inhibition, also called substrate reduction therapy:...

Word Count : 4006

Eliglustat

Last Update:

article in Journal of the American Medical Association the oral substrate reduction therapy resulted in "significant improvements in spleen volume, hemoglobin...

Word Count : 522

Lysosomal storage disease

Last Update:

specialized centers for a number of these diseases. In addition, substrate reduction therapy, a method used to decrease the production of storage material...

Word Count : 1819

Osteochondrodysplasia

Last Update:

Weinreb, NJ; Cox, TM (27 March 2015). "Enzyme replacement and substrate reduction therapy for Gaucher disease". The Cochrane Database of Systematic Reviews...

Word Count : 2857

Enzyme

Last Update:

The molecules upon which enzymes may act are called substrates, and the enzyme converts the substrates into different molecules known as products. Almost...

Word Count : 9774

Miglustat

Last Update:

that builds up when the enzyme doesn't work; this is called substrate reduction therapy. Miglustat is an iminosugar, a synthetic analogue of D-glucose...

Word Count : 1684

Statin

Last Update:

they will fit into the enzyme's active site and compete with the native substrate (HMG-CoA). This competition reduces the rate by which HMG-CoA reductase...

Word Count : 12890

Feminizing hormone therapy

Last Update:

Feminizing hormone therapy, also known as transfeminine hormone therapy, is hormone therapy and sex reassignment therapy to change the secondary sex characteristics...

Word Count : 24526

Cholesterol

Last Update:

Cholesterol regulates the biological process of substrate presentation and the enzymes that use substrate presentation as a mechanism of their activation...

Word Count : 8518

Atorvastatin

Last Update:

(80 mg) atorvastatin therapy is more effective than regular dose or low dose statin therapy at preventing CI-AKI. Atorvastatin therapy can also help to prevent...

Word Count : 9380

Photodynamic therapy

Last Update:

Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen...

Word Count : 9498

Opioid use disorder

Last Update:

therapy using methadone or buprenorphine. Such treatment reduces the risk of death. Additionally, they may benefit from cognitive behavioral therapy,...

Word Count : 12649

Ribonucleotide reductase

Last Update:

ferrous to ferric conversion to generate a tyrosyl free radical. Reduction of NDP substrates occurs under aerobic conditions. Class I reductases are divided...

Word Count : 3493

Drostanolone propionate

Last Update:

agonist of the androgen receptor (AR). It is not a substrate for 5α-reductase and is a poor substrate for 3α-hydroxysteroid dehydrogenase (3α-HSD), and...

Word Count : 1277

Solbinsiran

Last Update:

risk of cardiovascular disease. Solbinsiran is a GalNAc-conjugated Dicer-substrate siRNA (DsiRNA) that targets ANGPTL3 expression in the liver. ANGPTL3 plays...

Word Count : 293

Photosensitizer

Last Update:

sometimes they donate an electron to the substrate, sometimes they abstract a hydrogen atom from the substrate. At the end of this process, the photosensitizer...

Word Count : 2938

Substance dependence

Last Update:

spiritual-based approach to treating addiction. Therapy typically involves the use of cognitive-behavioral therapy, an approach that looks at the relationship...

Word Count : 6953

Insulin receptor substrate 1

Last Update:

Insulin receptor substrate 1 (IRS-1) is a signaling adapter protein that in humans is encoded by the IRS1 gene. It is a 131 kDa protein with amino acid...

Word Count : 4304

PDF Search Engine © AllGlobal.net